澳门新葡游戏(国际)官方VIP网站-ios/安卓版app下载

Our Science

Science & Innovation

Pipeline

Dorzagliatin

mGluR5

Poster and Presentation

Peer Reviewed Publications

Announcements and Circulars

Listing Documents

Investor Presentation

Portfolio Advisory Board

Senior Scientific Advisory Board

Product

> Product

> HuaTangNing(华堂宁®)

HuaTangNing(华堂宁®)

The following product information is for reference only by healthcare professionals. Please kindly refer to the Package Insert for more details.

HuaTangNing (华堂宁^®)

Mechanism

Dorzagliatin is an ectopic allosteric glucokinase (GK) full activator, which acts on glucokinase targets in pancreatic islets, intestinal endocrine cells, liver and other glucose storage and output organs, and improves impaired glucose-stimulated insulin secretion and GLP-1 secretion in Type 2 diabetes patients, and thus improves β-cell function and reduces insulin resistance. Thereby it improves blood glucose homeostasis in patients with Type 2 diabetes, and has a mechanism of restoring the physiological regulation of blood glucose homeostasis.

For Healthcare Professionals Only

Product Hotline：400-820-5552

【Product Name】

INN：Dorzagliatin Tablets

Brand Name: HuaTangNing (华堂宁^®)

【Composition】

Active ingredients: Dorzagliatin

【Dosage Form】

Light green to green, biconvex, round film-coated tablets, debossed with "H" on one side and "75" on the other side, white or off-white after coating removal

【Indication】

This product is used for adults with Type 2 Diabetes Mellitus.

Monotherapy: It can be used as mono-treatment, in parallel with diet control and exercise, to improve blood glucose control.

Combination therapy: When metformin hydrochloride alone has poor blood glucose control, on the basis of diet control and exercise, it can be used in combination with metformin hydrochloride to improve blood glucose control.

This product is contraindicated in patients with Type 1 Diabetes Mellitus, Diabetes ketoacidosis or hyperglycemia hyperosmolality

【Package】

14 tablets per blister, 28 tablets/pack

【Approval Number】

NMPA Approval No. H20220024

Please kindly refer to the Package Insert for more details of [Usage and dosage], [Adverse reactions], [Precautions], [Combination therapy] etc.

The above information is only intended for the reference of corporate product display without any promotion purpose.

About Us

Company Overview

Company History

Leadership Team

Portfolio Advisory Board